AMN Healthcare posts USD 673.24 million revenue: what it means for AMN Healthcare stock

Published on 10/25/2026 at 01:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AMN Healthcare beat second-quarter estimates at USD 673.24 million revenue. AMN Healthcare stock faces November 5 results after adjusted EPS reached USD 0.77.

Earnings and reporting date

AMN Healthcare generated USD 673.24 million in second-quarter revenue on August 6, 2026.
Adjusted earnings per share reached USD 0.77 versus USD 0.19 expected in the second quarter of 2026.
AMN Healthcare is scheduled to report third-quarter results on November 5, 2026.

AMN, US0017441017, Illustration mit AI erstellt.

AMN Healthcare (US0017441017) reported second-quarter 2026 revenue of USD 673.24 million and adjusted earnings per share of USD 0.77, compared with USD 0.19 expected. The results published for the August 6, 2026 report helped support renewed interest in the healthcare staffing provider, while the next results date is November 5, 2026.

Second-quarter results reset expectations

According to RTT News, AMN's second-quarter revenue rose 2.00 percent year over year to USD 673.24 million. Net income was USD 21.00 million, or USD 0.53 per share, compared with a net loss of USD 116.00 million, or USD 3.02 per share, in the year-earlier period.

The adjusted earnings figure also exceeded the USD 0.19 consensus estimate by USD 0.58. The comparison matters because the prior-year adjusted earnings figure was USD 0.30, leaving the latest result at USD 0.77.

What do the earnings mean?

The operating recovery remains uneven. Second-quarter revenue was 51.00 percent below the first quarter's USD 1.378 billion, according to the same RTT News report, which attributed the decline to an unusually large first-quarter labor disruption contribution. AMN's third-quarter revenue outlook was USD 640 million to USD 655 million, versus USD 634.50 million in the third quarter of 2025.

Three dates behind the move

On February 5, 2026, AMN reported fourth-quarter 2025 revenue of USD 748 million. On August 6, 2026, the company reported second-quarter revenue of USD 673.24 million and adjusted earnings per share of USD 0.77. On October 23, 2026, Investing.com reported a new 52-week high of USD 47.36.

November 5 is the next test

MarketBeat lists November 5, 2026 as the next reporting date, with a consensus estimate of USD 649.55 million in revenue and USD 0.2292 in earnings per share. That forecast implies revenue growth of 2.40 percent from USD 634.50 million in the year-earlier quarter, but adjusted earnings would be below the USD 0.77 reported for the second quarter.

NYSE valuation after the high

AMN closed at USD 48.03 on the NYSE on October 23, 2026. The finance profile identifies AMN Healthcare as a healthcare company in the medical care facilities industry, while its market capitalization was USD 1.9 billion and its 52-week range was USD 14.97 to USD 48.19 as of October 23, 2026.

The further course of trading is shown by the continuously updated real-time quote of AMN stock.